Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy.

Diaz PI, Hong BY, Dupuy AK, Choquette L, Thompson A, Salner AL, Schauer PK, Hegde U, Burleson JA, Strausbaugh LD, Peterson DE, Dongari-Bagtzoglou A.

J Fungi (Basel). 2019 Jun 13;5(2). pii: E49. doi: 10.3390/jof5020049.

2.

Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.

Hong BY, Sobue T, Choquette L, Dupuy AK, Thompson A, Burleson JA, Salner AL, Schauer PK, Joshi P, Fox E, Shin DG, Weinstock GM, Strausbaugh LD, Dongari-Bagtzoglou A, Peterson DE, Diaz PI.

Microbiome. 2019 Apr 25;7(1):66. doi: 10.1186/s40168-019-0679-5.

3.

Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection.

Bertolini M, Ranjan A, Thompson A, Diaz PI, Sobue T, Maas K, Dongari-Bagtzoglou A.

PLoS Pathog. 2019 Apr 22;15(4):e1007717. doi: 10.1371/journal.ppat.1007717. eCollection 2019 Apr.

4.

Tipping the Balance: C. albicans Adaptation in Polymicrobial Environments.

Ranjan A, Dongari-Bagtzoglou A.

J Fungi (Basel). 2018 Sep 18;4(3). pii: E112. doi: 10.3390/jof4030112. Review.

5.

Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model.

Sobue T, Bertolini M, Thompson A, Peterson DE, Diaz PI, Dongari-Bagtzoglou A.

Mol Oral Microbiol. 2018 Jun;33(3):212-223. doi: 10.1111/omi.12214. Epub 2018 Feb 20.

6.

Chemotherapy Induces Oral Mucositis in Mice Without Additional Noxious Stimuli.

Bertolini M, Sobue T, Thompson A, Dongari-Bagtzoglou A.

Transl Oncol. 2017 Aug;10(4):612-620. doi: 10.1016/j.tranon.2017.05.001. Epub 2017 Jun 27.

7.

S. oralis activates the Efg1 filamentation pathway in C. albicans to promote cross-kingdom interactions and mucosal biofilms.

Xu H, Sobue T, Bertolini M, Thompson A, Vickerman M, Nobile CJ, Dongari-Bagtzoglou A.

Virulence. 2017 Nov 17;8(8):1602-1617. doi: 10.1080/21505594.2017.1326438. Epub 2017 Jun 1.

8.

Clinical, Immune, and Microbiome Traits of Gingivitis and Peri-implant Mucositis.

Schincaglia GP, Hong BY, Rosania A, Barasz J, Thompson A, Sobue T, Panagakos F, Burleson JA, Dongari-Bagtzoglou A, Diaz PI.

J Dent Res. 2017 Jan;96(1):47-55. doi: 10.1177/0022034516668847. Epub 2016 Oct 8.

PMID:
28033066
9.

Streptococcus oralis and Candida albicans Synergistically Activate μ-Calpain to Degrade E-cadherin From Oral Epithelial Junctions.

Xu H, Sobue T, Bertolini M, Thompson A, Dongari-Bagtzoglou A.

J Infect Dis. 2016 Sep 15;214(6):925-34. doi: 10.1093/infdis/jiw201. Epub 2016 May 13.

10.

Experimental Models of C. albicans-Streptococcal Co-infection.

Sobue T, Diaz P, Xu H, Bertolini M, Dongari-Bagtzoglou A.

Methods Mol Biol. 2016;1356:137-52. doi: 10.1007/978-1-4939-3052-4_10.

PMID:
26519070
11.

Shaping the oral mycobiota: interactions of opportunistic fungi with oral bacteria and the host.

Xu H, Dongari-Bagtzoglou A.

Curr Opin Microbiol. 2015 Aug;26:65-70. doi: 10.1016/j.mib.2015.06.002. Epub 2015 Jun 19. Review.

12.

Candida-streptococcal mucosal biofilms display distinct structural and virulence characteristics depending on growth conditions and hyphal morphotypes.

Bertolini MM, Xu H, Sobue T, Nobile CJ, Del Bel Cury AA, Dongari-Bagtzoglou A.

Mol Oral Microbiol. 2015 Aug;30(4):307-22. doi: 10.1111/omi.12095. Epub 2015 Apr 20.

13.

Fungal-bacterial interactions and their relevance to oral health: linking the clinic and the bench.

Diaz PI, Strausbaugh LD, Dongari-Bagtzoglou A.

Front Cell Infect Microbiol. 2014 Jul 29;4:101. doi: 10.3389/fcimb.2014.00101. eCollection 2014. Review.

14.

Antifungal medications or disinfectants for denture stomatitis.

Lalla RV, Dongari-Bagtzoglou A.

Evid Based Dent. 2014 Jun;15(2):61-2. doi: 10.1038/sj.ebd.6401032.

PMID:
24971864
15.

Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease.

Xu H, Jenkinson HF, Dongari-Bagtzoglou A.

Mol Oral Microbiol. 2014 Jun;29(3):99-116. Review.

16.

Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal.

Dupuy AK, David MS, Li L, Heider TN, Peterson JD, Montano EA, Dongari-Bagtzoglou A, Diaz PI, Strausbaugh LD.

PLoS One. 2014 Mar 10;9(3):e90899. doi: 10.1371/journal.pone.0090899. eCollection 2014.

17.

Streptococcus gordonii glucosyltransferase promotes biofilm interactions with Candida albicans.

Ricker A, Vickerman M, Dongari-Bagtzoglou A.

J Oral Microbiol. 2014 Jan 29;6. doi: 10.3402/jom.v6.23419. eCollection 2014.

18.

Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response.

Xu H, Sobue T, Thompson A, Xie Z, Poon K, Ricker A, Cervantes J, Diaz PI, Dongari-Bagtzoglou A.

Cell Microbiol. 2014 Feb;16(2):214-31. doi: 10.1111/cmi.12216. Epub 2013 Oct 17.

19.

Glucanase induces filamentation of the fungal pathogen Candida albicans.

Xu H, Nobile CJ, Dongari-Bagtzoglou A.

PLoS One. 2013 May 30;8(5):e63736. doi: 10.1371/journal.pone.0063736. Print 2013.

20.

Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies.

Lalla RV, Patton LL, Dongari-Bagtzoglou A.

J Calif Dent Assoc. 2013 Apr;41(4):263-8. Review.

PMID:
23705242
21.

Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome.

Diaz PI, Hong BY, Frias-Lopez J, Dupuy AK, Angeloni M, Abusleme L, Terzi E, Ioannidou E, Strausbaugh LD, Dongari-Bagtzoglou A.

Clin Vaccine Immunol. 2013 Jun;20(6):920-30. doi: 10.1128/CVI.00734-12. Epub 2013 Apr 24.

22.

Response to the review by Fisher and Ma.

Ioannidou E, Swede H, Dongari-Bagtzoglou A.

J Evid Based Dent Pract. 2013 Mar;13(1):39-40. doi: 10.1016/j.jebdp.2012.12.001. No abstract available.

23.

Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing.

Xie Z, Thompson A, Sobue T, Kashleva H, Xu H, Vasilakos J, Dongari-Bagtzoglou A.

J Infect Dis. 2012 Dec 15;206(12):1936-45. doi: 10.1093/infdis/jis607. Epub 2012 Oct 2.

24.

Using high throughput sequencing to explore the biodiversity in oral bacterial communities.

Diaz PI, Dupuy AK, Abusleme L, Reese B, Obergfell C, Choquette L, Dongari-Bagtzoglou A, Peterson DE, Terzi E, Strausbaugh LD.

Mol Oral Microbiol. 2012 Jun;27(3):182-201. doi: 10.1111/j.2041-1014.2012.00642.x. Epub 2012 Mar 3.

25.

Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model.

Diaz PI, Xie Z, Sobue T, Thompson A, Biyikoglu B, Ricker A, Ikonomou L, Dongari-Bagtzoglou A.

Infect Immun. 2012 Feb;80(2):620-32. doi: 10.1128/IAI.05896-11. Epub 2011 Nov 21.

26.

Periodontitis predicts elevated C-reactive protein levels in chronic kidney disease.

Ioannidou E, Swede H, Dongari-Bagtzoglou A.

J Dent Res. 2011 Dec;90(12):1411-5. doi: 10.1177/0022034511423394. Epub 2011 Sep 22.

27.

A quantitative real-time RT-PCR assay for mature C. albicans biofilms.

Xie Z, Thompson A, Kashleva H, Dongari-Bagtzoglou A.

BMC Microbiol. 2011 May 6;11:93. doi: 10.1186/1471-2180-11-93.

28.

Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion.

Dwivedi P, Thompson A, Xie Z, Kashleva H, Ganguly S, Mitchell AP, Dongari-Bagtzoglou A.

PLoS One. 2011 Jan 25;6(1):e16218. doi: 10.1371/journal.pone.0016218.

29.

Host cell invasion and virulence mediated by Candida albicans Ssa1.

Sun JN, Solis NV, Phan QT, Bajwa JS, Kashleva H, Thompson A, Liu Y, Dongari-Bagtzoglou A, Edgerton M, Filler SG.

PLoS Pathog. 2010 Nov 11;6(11):e1001181. doi: 10.1371/journal.ppat.1001181.

30.

Periodontitis and inflammatory markers in transplant recipients.

Shaqman M, Ioannidou E, Burleson J, Hull D, Dongari-Bagtzoglou A.

J Periodontol. 2010 May;81(5):666-72. doi: 10.1902/jop.2010.090570.

PMID:
20429646
31.

Periodontitis case definition affects the association with renal function in kidney transplant recipients.

Ioannidou E, Shaqman M, Burleson J, Dongari-Bagtzoglou A.

Oral Dis. 2010 Oct;16(7):636-42. doi: 10.1111/j.1601-0825.2010.01665.x.

32.

Characterization of mucosal Candida albicans biofilms.

Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J.

PLoS One. 2009 Nov 24;4(11):e7967. doi: 10.1371/journal.pone.0007967.

33.

Epithelial GM-CSF induction by Candida glabrata.

Li L, Dongari-Bagtzoglou A.

J Dent Res. 2009 Aug;88(8):746-51. doi: 10.1177/0022034509341266.

34.

Oral Candida infection and colonization in solid organ transplant recipients.

Dongari-Bagtzoglou A, Dwivedi P, Ioannidou E, Shaqman M, Hull D, Burleson J.

Oral Microbiol Immunol. 2009 Jun;24(3):249-54. doi: 10.1111/j.1399-302X.2009.00505.x.

35.

Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.

Villar CC, Dongari-Bagtzoglou A.

Expert Rev Mol Med. 2008 Oct 13;10:e29. doi: 10.1017/S1462399408000835. Review.

36.

A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia.

Dwivedi PP, Mallya S, Dongari-Bagtzoglou A.

Med Mycol. 2009 Mar;47(2):157-67. doi: 10.1080/13693780802165797. Epub 2008 Jun 10.

37.

Pathogenesis of mucosal biofilm infections: challenges and progress.

Dongari-Bagtzoglou A.

Expert Rev Anti Infect Ther. 2008 Apr;6(2):201-8. doi: 10.1586/14787210.6.2.201. Review.

38.

Mucosal biofilms: challenges and future directions.

Dongari-Bagtzoglou A.

Expert Rev Anti Infect Ther. 2008 Apr;6(2):141-4. doi: 10.1586/14787210.6.2.141. No abstract available.

PMID:
18380594
39.

Differential regulation of innate immune response genes in gingival epithelial cells stimulated with Aggregatibacter actinomycetemcomitans.

Laube DM, Dongari-Bagtzoglou A, Kashleva H, Eskdale J, Gallagher G, Diamond G.

J Periodontal Res. 2008 Feb;43(1):116-23. Epub 2007 Nov 13.

PMID:
18004991
40.

Letter to the Editor: Authors' Response to Pitiphat et al.

Ioannidou E, Malekzadeh T, Dongari-Bagtzoglou A.

J Periodontol. 2007 Jul;78(7):1186-1187. doi: 10.1902/jop.2007.070218. No abstract available.

PMID:
29539157
41.

Oral epithelium-Candida glabrata interactions in vitro.

Li L, Dongari-Bagtzoglou A.

Oral Microbiol Immunol. 2007 Jun;22(3):182-7.

PMID:
17488444
42.
43.

Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p.

Villar CC, Kashleva H, Nobile CJ, Mitchell AP, Dongari-Bagtzoglou A.

Infect Immun. 2007 May;75(5):2126-35. Epub 2007 Mar 5.

44.

Candida glabrata: an emerging oral opportunistic pathogen.

Li L, Redding S, Dongari-Bagtzoglou A.

J Dent Res. 2007 Mar;86(3):204-15. Review.

PMID:
17314251
45.

Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models.

Li L, Kashleva H, Dongari-Bagtzoglou A.

Microb Pathog. 2007 Apr;42(4):138-47. Epub 2007 Jan 19.

46.
47.

Effect of periodontal treatment on serum C-reactive protein levels: a systematic review and meta-analysis.

Ioannidou E, Malekzadeh T, Dongari-Bagtzoglou A.

J Periodontol. 2006 Oct;77(10):1635-42. Review.

PMID:
17032104
48.

Therapeutic modulation of cytokines in chronic infectious diseases.

Villar CC, Dongari-Bagtzoglou A.

Curr Pharm Des. 2006;12(19):2329-48. Review.

PMID:
16842182
49.

Development of a novel three-dimensional in vitro model of oral Candida infection.

Dongari-Bagtzoglou A, Kashleva H.

Microb Pathog. 2006 Jun;40(6):271-8. Epub 2006 Apr 19.

PMID:
16626928
50.

Candida albicans-infected oral epithelial cells augment the anti-fungal activity of human neutrophils in vitro.

Dongari-Bagtzoglou A, Villar CC, Kashleva H.

Med Mycol. 2005 Sep;43(6):545-9.

PMID:
16323311

Supplemental Content

Loading ...
Support Center